Cross-Clade Protective Immune Responses to Influenza Viruses with H5N1 HA and NA Elicited by an Influenza Virus-Like Particle
Rick A. Bright(Waterford Institute), Ted M. Ross(Cleveland Clinic), Corey J. Crevar(University of Pittsburgh), Donald M. Carter(Vaccine & Gene Therapy Institute of Florida), Peter Pushko(Novavax (United States)), Franklin R. Toapanta(University of Maryland, Baltimore), Terrence M. Tumpey(Centers for Disease Control and Prevention), Niranjan M. Kumar(Scripps Clinic), Gale Smith(Novavax (United States)), Jonathan D. Steckbeck(University of Pittsburgh), Kelly Stefano Cole(University of Pittsburgh)
Cited by 240
Related Papers
Incidence of adamantane resistance among influenza A (H3N2) viruses isolated worldwide from 1994 to 2005: a cause for concern
|The Lancet|2005|734
Adamantane Resistance Among Influenza A Viruses Isolated Early During the 2005-2006 Influenza Season in the United States
|JAMA|2006|672
Transmission of Equine Influenza Virus to Dogs
|Science|2005|652
A Two-Amino Acid Change in the Hemagglutinin of the 1918 Influenza Virus Abolishes Transmission
|Science|2007|582
Surveillance of Resistance to Adamantanes among Influenza A(H3N2) and A(H1N1) Viruses Isolated Worldwide
|The Journal of Infectious Diseases|2007|547